Related Experiment Video
Updated: Feb 5, 2026

Evaluating Autophagy Levels in Two Different Pancreatic Cell Models Using LC3 Immunofluorescence
Published on: April 28, 2023
Telmisartan attenuates kidney apoptosis and autophagy-related protein expression levels in an intermittent hypoxia
Xiao-Bin Zhang1,2,3,4,5, Jing-Huang Cai1,2, Yu-Yun Yang1,2
1Department of Respiratory Medicine, Zhongshan Hospital, Xiamen University, No.201, Hubin Nan Road, Siming District, Xiamen, 361004, Fujian Province, People's Republic of China.
Purpose:
Obstructive sleep apnea (OSA) is associated with renal impairs. As a novel pathophysiological hallmark of OSA, chronic intermittent hypoxia (CIH) enhances apoptosis and autophagy. The present study aims to evaluate the effect of telmisartan on CIH-induced kidney apoptosis and autophagy in a mouse model of OSA.
Materials And Methods:
Mice were randomly allocated to normoxia, CIH, and CIH+telmisartan groups (n = 12 in each group). The CIH exposure duration was 12 weeks. Mice in the CIH+telmisartan group received telmisartan administration. The terminal deoxynucleotidyl transferase dUTP nick-end labeling (TUNEL) assay and western blotting of Bax and cleaved caspase-3 were conducted for evaluating apoptosis in kidney tissue. While the autophagy-related proteins, beclin-1 and LC3, were also observed via western blotting.
Results:
The percentage of apoptotic cell in the CIH group was significantly higher than that of normoxia group; meanwhile, Bax and cleaved caspase-3 protein levels were increased in the CIH group than those of normoxia group (all p < 0.05). Compared with the normoxia group, mice in the CIH group had greater autophagy-related proteins (beclin-1 and LC3) expression. When compared to the CIH group, both the renal apoptosis and autophagy in the CIH+telmisartan group were decreased.
Conclusion:
The CIH accelerates renal apoptosis and autophagy levels. Telmisartan ameliorating those levels suggests that it might prevent renal impairs from the CIH in OSA patients.
Insights
Obstructive sleep apnea causes kidney damage by increasing cell death and autophagy. Telmisartan treatment reduced these effects in a mouse model, suggesting potential renal benefits for patients.
Area of Science:
- Renal pathology
- Sleep medicine
- Cellular biology
Background:
- Obstructive sleep apnea (OSA) is linked to kidney impairment.
- Chronic intermittent hypoxia (CIH), a key feature of OSA, promotes apoptosis and autophagy.
- Understanding the mechanisms of CIH-induced renal damage is crucial.
Purpose of the Study:
- To investigate the effect of telmisartan on CIH-induced kidney apoptosis and autophagy.
- To evaluate telmisartan as a potential therapeutic agent for OSA-related renal dysfunction.
Main Methods:
- A mouse model of OSA was established using chronic intermittent hypoxia (CIH) for 12 weeks.
- Mice were divided into normoxia, CIH, and CIH+telmisartan groups.
- Kidney apoptosis was assessed using TUNEL assay and western blotting for Bax and cleaved caspase-3.
- Autophagy markers (beclin-1 and LC3) were analyzed via western blotting.
Main Results:
- CIH significantly increased renal apoptosis and autophagy markers (Bax, cleaved caspase-3, beclin-1, LC3) compared to normoxia (p < 0.05).
- Telmisartan administration in the CIH+telmisartan group significantly decreased both apoptosis and autophagy levels in kidney tissue compared to the CIH group.
Conclusions:
- CIH accelerates renal apoptosis and autophagy, contributing to kidney damage in OSA.
- Telmisartan demonstrated a protective effect by ameliorating CIH-induced renal apoptosis and autophagy.
- These findings suggest telmisartan may prevent renal impairment in patients with obstructive sleep apnea.
Related Concept Videos
Transcription Attenuation in Prokaryotes
There are several different mechanisms used to attenuate transcription. In ribosome mediated...
Apoptosis
Kidney Structure
Autophagy
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
Hypoxia
Types of Hypoxia
There are four primary types of hypoxia, each resulting from a different cause:
1. Anemic hypoxia: This type occurs due to insufficient oxygen delivery caused by a lack of red blood cells (RBCs) or RBCs with abnormal or...
Leveling Effect

